COVID‐19 infection in patients with history of pediatric heart transplant in Germany, Austria, and Switzerland
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15272 ↗At a glance
Multizentrische Studie in Clinical Transplantation, 2024. Written by Sarah Ulrich and 18 co-authors. Institution: Department for Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munchen, Germany. Major MEDLINE topics: COVID-19, Heart Transplantation. 34 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
COVID‐19 is a heterogenous infection—asymptomatic to fatal. While the course of pediatric COVID‐19 infections is usually mild or even asymptomatic, individuals after adult heart transplantation are at high risk of a severe infection. We conducted a retrospective, multicenter survey of 16 pediatric heart transplant centers in Germany, Austria and Switzerland to evaluate the risk of a severe COVID‐19 infection after pediatric heart transplantation between 02/2020 and 06/2021. Twenty‐six subjects (11 male) with a median age of 9.77 years at time of transplantation and a median of 4.65 years after transplantation suffered from COVID‐19 infection. The median age at time of COVID‐10 infection was 17.20 years. Fourteen subjects had an asymptomatic COVID‐19 infection. The most frequent symptoms were myalgia/fatigue ( n = 6), cough ( n = 5), rhinitis ( n = 5), and loss of taste ( n = 5). Only one subject showed dyspnea. Eleven individuals needed therapy in an outpatient setting, four subjects were hospitalized. One person needed oxygen supply, none of the subjects needed non‐invasive or invasive mechanical ventilation. No specific signs for graft dysfunction were found by non‐invasive testing. In pediatric heart transplant subjects, COVID‐19 infection was mostly asymptomatic or mild. There were no SARS‐CoV‐2 associated myocardial dysfunction in heart transplant individuals.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department for Pediatric Cardiology and Intensive Care Medicine, Ludwig-Maximilians-University Munich, Munchen, Germany.
- Department of Pediatric Cardiology, University Children's Hospital Zürich, Zurich, Switzerland.
- Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.
- Center of Congenital Heart Disease/Pediatric Cardiology, HDZ-NRW, Ruhr-University, Bad Oeynhausen, Germany.
- Department of Pediatric Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.
- Department of Pediatric Cardiology, University Hospital Münster, Münster, Germany.
ORCID profiles: Sarah Ulrich
Cite
APA
Ulrich, S., Balmer, C., Becker, K., Bruhs, J., Danne, F., Debus, V., Dewein, L., Di-Bernardo, S., Doll, U., Fleck, T., Tirilomis, T., Glöckler, M., Grafmann, M., Greil, S., Grosser, U., Saur, P., Skrzypek, S., Steinmetz, M., & Working group thoracic organ transplantation DGPK (2024). COVID‐19 infection in patients with history of pediatric heart transplant in Germany, Austria, and Switzerland. Clinical Transplantation. https://doi.org/10.1111/ctr.15272
Vancouver
Ulrich S, Balmer C, Becker K, Bruhs J, Danne F, Debus V, et al. COVID‐19 infection in patients with history of pediatric heart transplant in Germany, Austria, and Switzerland. Clinical Transplantation. 2024. doi:10.1111/ctr.15272
BibTeX
@article{Ulrich2024,
author = {Ulrich, Sarah and Balmer, Christian and Becker, Kolja and Bruhs, Josefin and Danne, Friederike and Debus, Volker and Dewein, Leonie and Di-Bernardo, Stefano and Doll, Ulrike and Fleck, Thilo and Tirilomis, Theodor and Glöckler, Martin and Grafmann, Maria and Greil, Sabine and Grosser, Urte and Saur, Patrick and Skrzypek, Susanne and Steinmetz, Michael and Working group thoracic organ transplantation DGPK, Working group thoracic organ transplantation DGPK},
title = {COVID‐19 infection in patients with history of pediatric heart transplant in Germany, Austria, and Switzerland},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15272}
}
EUVIMED